Vitamin D increases the likelihood that breast cancer will disappear with chemotherapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 8-Jul-2025 05:10 ET (8-Jul-2025 09:10 GMT/UTC)
Cancer cells have evolved numerous strategies to suppress immune cells like NK cells, even when these cancer cell are producing the immune boosting factor IL-15. An obvious solution is to supply cancer patients with drugs that trigger the IL-15 receptor on immune cells, however these approaches have proven too toxic for patients because they boosts the activity of immune cells in every tissue, not just in the tumour, resulting in severe side-effects.
Until now.
A team of researchers at Monash University and oNKo-Innate in Melbourne, Australia have found a gene that can be switched off in NK cells which makes them extremely sensitive to the body’s own IL-15, opening the way for the development of a new therapy to treat cancer.
Virginia Tech researchers have created an engineered model of the supportive tissue found within a lymph node to study human health. Working with scientists at the University of Virginia, the researchers are building a bioengineered model of a human lymph node, which performs essential roles in the immune system throughout the body.
With support from a three-year, $1.85 million grant from the U.S. Department of Defense (“Role of TBX2 in the establishment of the Prostate Cancer Pre-Metastatic Niche (PMN) in the Bone”), Srinivas Nandana, Ph.D., and Manisha Tripathi, Ph.D., from the Department of Cell Biology and Biochemistry at the TTUHSC School of Medicine seek to advance the understanding of prostate cancer metastasis by investigating the role of TBX2 in establishing the prostate cancer premetastatic niche in bone.
Hyperthermia, a cancer treatment using controlled heat to kill tumor cells, shows promise but faces limitations due to some tumor cells' unexpected heat resistance. Researchers from Japan have now discovered that high cholesterol levels in cancer cell membranes act as a protective barrier, shielding against heat-induced membrane breakdown. When cholesterol was depleted using drugs, previously heat-resistant tumors became vulnerable to hyperthermia treatment, opening new possibilities for personalized cancer therapy targeting cholesterol levels to improve outcomes.